Recombinant proteins

Results: 847



#Item
21Microsoft Word - Key Findings-2009 TX TTD Report.doc

Microsoft Word - Key Findings-2009 TX TTD Report.doc

Add to Reading List

Source URL: www.dfwbgh.org

Language: English - Date: 2012-01-31 23:34:54
22For immediate release 26 May 2016 AFSTYLA® (rFVIII-Single Chain) – FDA approval CSL Limited (ASX:CSL; USOTC:CSLLY) - CSL today announced that the US Food and Drug Administration (FDA) has approved AFSTYLA® [Antihaemo

For immediate release 26 May 2016 AFSTYLA® (rFVIII-Single Chain) – FDA approval CSL Limited (ASX:CSL; USOTC:CSLLY) - CSL today announced that the US Food and Drug Administration (FDA) has approved AFSTYLA® [Antihaemo

Add to Reading List

Source URL: www.csl.com.au

Language: English - Date: 2016-05-25 20:22:52
23This material is intended for Canadian media only. Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes and a comparable HbA1c reduction in type 2 diabetes versus NovoRap

This material is intended for Canadian media only. Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes and a comparable HbA1c reduction in type 2 diabetes versus NovoRap

Add to Reading List

Source URL: www.novonordisk.ca

Language: English - Date: 2016-08-18 19:09:23
24ANNEX TO GUIDELINE ON SIMILAR BIOLOGICAL MEDICINAL PRODUCTS CONTAINING BIOTECHNOLOGY-DERIVED PROTEINS AS ACTIVE SUBSTANCE: NON-CLINICAL AND CLINICAL ISSUES GUIDANCE ON SIMILAR MEDICINAL PRODUCTS CONTAINING RECOMBINANT G

ANNEX TO GUIDELINE ON SIMILAR BIOLOGICAL MEDICINAL PRODUCTS CONTAINING BIOTECHNOLOGY-DERIVED PROTEINS AS ACTIVE SUBSTANCE: NON-CLINICAL AND CLINICAL ISSUES GUIDANCE ON SIMILAR MEDICINAL PRODUCTS CONTAINING RECOMBINANT G

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-07-21 04:57:44
    25Cytokines and Growth Factors Recombinant Human Proteins Expressed in Human Cells Animal Component-Free and Xeno-Free PRICE LIST AS OF SEPTEMBER 2015 Cat. No.

    Cytokines and Growth Factors Recombinant Human Proteins Expressed in Human Cells Animal Component-Free and Xeno-Free PRICE LIST AS OF SEPTEMBER 2015 Cat. No.

    Add to Reading List

    Source URL: www.humanzyme.com

    Language: English - Date: 2015-10-01 17:03:00
      26Advances in Recombinant Protein Technology 2013 A meeting jointly organized by AstraZeneca, University of Manchester and ELRIG The ability to produce proteins (as reagents or biotherapeutics) of sufficient quality and qu

      Advances in Recombinant Protein Technology 2013 A meeting jointly organized by AstraZeneca, University of Manchester and ELRIG The ability to produce proteins (as reagents or biotherapeutics) of sufficient quality and qu

      Add to Reading List

      Source URL: www.phynexus.com

      Language: English - Date: 2013-11-14 00:35:30
        27At EMD Serono, your safety is our first priority. That’s why we created Check My MedsTM — a smartphone application to help you and your healthcare professional verify the

        At EMD Serono, your safety is our first priority. That’s why we created Check My MedsTM — a smartphone application to help you and your healthcare professional verify the

        Add to Reading List

        Source URL: www.nabp.net

        Language: English
        28Cytokines and Growth Factors Recombinant Human Proteins Expressed in Human Cells Animal Component-Free and Xeno-Free PRICE LIST AS OF SEPTEMBER 2015 Cat. No.

        Cytokines and Growth Factors Recombinant Human Proteins Expressed in Human Cells Animal Component-Free and Xeno-Free PRICE LIST AS OF SEPTEMBER 2015 Cat. No.

        Add to Reading List

        Source URL: www.humanzyme.com

        Language: English - Date: 2015-10-01 17:03:00
          29Inpatient Glycemic Management Non-Critical Care Adults Mary Jean Christian, MA, MBA, RD, CDE DISCLOSURES

          Inpatient Glycemic Management Non-Critical Care Adults Mary Jean Christian, MA, MBA, RD, CDE DISCLOSURES

          Add to Reading List

          Source URL: www.healthaffairs.uci.edu

          Language: English - Date: 2015-09-21 16:30:30
          30Advances in Recombinant Protein Technology 2013 A meeting jointly organized by AstraZeneca, University of Manchester and ELRIG The ability to produce proteins (as reagents or biotherapeutics) of sufficient quality and qu

          Advances in Recombinant Protein Technology 2013 A meeting jointly organized by AstraZeneca, University of Manchester and ELRIG The ability to produce proteins (as reagents or biotherapeutics) of sufficient quality and qu

          Add to Reading List

          Source URL: phynexus.com

          Language: English - Date: 2013-11-14 00:35:30